NEW YORK, March 08, 2016 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Chris Pasquale will join the equity research department as a Director covering the Medical Supplies and Devices sector. He will commence work at Guggenheim in April.
Mr. Pasquale will be coming to Guggenheim from J.P. Morgan, where he worked on the top-ranked medical supplies and devices team, according to the Institutional Investor Magazine 2015 Rankings.
“We are excited to have Chris on our Healthcare team,” said John Hervey, Director of Research at Guggenheim Securities. “His company coverage brings an important new dimension to our Healthcare coverage; strengthens the outstanding fundamental research team of Tony Butler, Louise Chen, and Bill Tanner; as well as complements the outstanding policy research that we produce through our Washington Research Group.”
Mr. Pasquale earned his B.S. at Duke University. He will operate out of Philadelphia, where he resides.
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers a full range of services that fall into four broad categories: Advisory, Sales and Trading, Financing, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Atlanta, Boston, Chicago, Los Angeles, and San Francisco. For more information, visit guggenheimpartners.com.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $240 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1Assets under management are as of 12.31.2015 and include consulting services for clients whose assets are valued at approximately $47bn.
Media Contact Ellen Cunningham Guggenheim Partners 212.518.9578 [email protected]


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



